<?xml version='1.0' encoding='UTF-8'?><codeBook xmlns="ddi:codebook:2_5" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="ddi:codebook:2_5 https://ddialliance.org/Specification/DDI-Codebook/2.5/XMLSchema/codebook.xsd" version="2.5"><docDscr><citation><titlStmt><titl>Single Incision Device (TVT Secur) Versus Retropubic Tension-free Vaginal Tape Device (TVT) for the Management of Stress Urinary Incontinence in Women: A Randomized Clinical Trial</titl><IDNo agency="DOI">doi:10.7939/DVN/10962</IDNo></titlStmt><distStmt><distrbtr source="archive">UAL Dataverse</distrbtr><distDate>2016-12-05</distDate></distStmt><verStmt source="DVN"><version date="2017-05-29" type="RELEASED">1</version></verStmt><biblCit>Ross, Sue; Tang, Selphee; Schulz, Jane; Murphy, Magnus; Goncalves, Jose; Kaye, Stephen; Dederer, Lorel; Robert, Magali, 2016, "Single Incision Device (TVT Secur) Versus Retropubic Tension-free Vaginal Tape Device (TVT) for the Management of Stress Urinary Incontinence in Women: A Randomized Clinical Trial", https://doi.org/10.7939/DVN/10962, UAL Dataverse, V1</biblCit></citation></docDscr><stdyDscr><citation><titlStmt><titl>Single Incision Device (TVT Secur) Versus Retropubic Tension-free Vaginal Tape Device (TVT) for the Management of Stress Urinary Incontinence in Women: A Randomized Clinical Trial</titl><altTitl>Tension-free Vaginal Tape Management of Stress Incontinence in Women: Randomized Trial of TVT Secur Versus TVT</altTitl><IDNo agency="DOI">doi:10.7939/DVN/10962</IDNo><IDNo agency="ClinicalTrials.gov">NCT00685217</IDNo></titlStmt><rspStmt><AuthEnty affiliation="University of Alberta">Ross, Sue</AuthEnty><AuthEnty affiliation="University of Calgary">Tang, Selphee</AuthEnty><AuthEnty affiliation="University of Alberta">Schulz, Jane</AuthEnty><AuthEnty affiliation="University of Calgary">Murphy, Magnus</AuthEnty><AuthEnty affiliation="Penticton Regional Hospital">Goncalves, Jose</AuthEnty><AuthEnty affiliation="Lions Gate Hospital">Kaye, Stephen</AuthEnty><AuthEnty affiliation="University of Calgary">Dederer, Lorel</AuthEnty><AuthEnty affiliation="University of Calgary">Robert, Magali</AuthEnty></rspStmt><prodStmt><producer affiliation="University of Alberta">Ross, Sue</producer><producer affiliation="University of Alberta">Schulz, Jane</producer><producer affiliation="University of Calgary">Robert, Magali</producer><prodDate>2008</prodDate><prodPlac>Calgary, Alberta; Edmonton, Alberta; Penticton, British Columbia; Vancouver, British Columbia</prodPlac><software>Microsoft Access</software><software version="9.3">SAS</software></prodStmt><distStmt><distrbtr source="archive">UAL Dataverse</distrbtr><contact affiliation="University of Alberta" email="Sue.Ross@albertahealthservices.ca">Ross, Sue</contact></distStmt></citation><stdyInfo><subject><keyword>Medicine, Health and Life Sciences</keyword><keyword>single incision device</keyword><keyword>stress urinary incontinence</keyword><keyword>surgical treatment</keyword><keyword>effectiveness</keyword><keyword vocab="MeSH" vocabURI="https://www.nlm.nih.gov/mesh/">randomized controlled trial</keyword></subject><abstract>The objective of this Canadian multi-centre pragmatic randomized controlled trial was to compare the effectiveness of the new single-incision device, Gynecare TVT Secur, to the established predecate retropubic TVT device, in terms of objective cure of stress urinary incontinence (SUI) at 12 months postoperatively. Other outcomes included: complications, symptoms, and incontinence-related quality of life.</abstract><sumDscr><timePrd cycle="P1" event="start" date="2008-05">2008-05</timePrd><timePrd cycle="P1" event="end" date="2012-04">2012-04</timePrd><collDate cycle="P1" event="start" date="2008-05">2008-05</collDate><collDate cycle="P1" event="end" date="2011-03">2011-03</collDate><dataKind>Questionnaire data; Clinical data</dataKind><nation>Canada</nation><geogCover>Calgary, Alberta; Edmonton, Alberta; Vancouver, British Columbia; Penticton, British Columbia</geogCover><anlyUnit>Individuals</anlyUnit><universe>Women with stress incontinence, defined as leaking with increased abdominal pressure.</universe></sumDscr></stdyInfo><method><dataColl><frequenc>Data was collected at baseline and one year postoperative.</frequenc><sampProc>The sample size estimate for our trial was 300, but the trial stopped early because of poor recruitment. 74 women participated (40 allocated to TVT Secur, 34 to TVT). Data was collected and analysed for 33/40 (83%) of the TVT Secur group and 28/34 (89%) of the TVT group.</sampProc><sources><dataSrc>Urogenital Distress Inventory (UDI-6); Incontinence Impact Questionnaire (IIQ-7); the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire-12, (PISQ-12); the 15D Instrument of Health-related Quality of Life (15D) was included for the proposed economic evaluation which was never done.</dataSrc></sources><collMode>Self-administered questionnaire: Paper; Self-administered writings and/or diaries; Physical measurements and tests; Chart review</collMode><collSitu>The trial ended early because of poor recruitment.</collSitu><actMin>Emails were sent out two months before the year follow-up to schedule the appointment and reminders were sent one month before the appointment. If the participant was unable to come in person, questionnaires were sent by mail. Additional contacts were collected for study participants in the event that they were hard to reach or had moved.</actMin><cleanOps>The data entry clerk entered data, and the statistician and data entry clerk checked over all data before analysis. Data was checked for outliers, and range and logic checks were performed. Paper forms were kept and were compared to electronic records in the event of missing or outlying data.</cleanOps></dataColl><anlyInfo/></method><dataAccs><setAvail><accsPlac>Paper copies are archived at Iron Mountain. Electronic database is hosted on a server at the University of Calgary.</accsPlac><avlStatus>Available</avlStatus></setAvail><useStmt><conditions>Access to deidentified data may be permitted for external researchers, with limitations. Only researchers with REB-approved projects may be permitted access to the deidentified data. The data producer determines access on a case-by-case basis. Contact the data producer directly to discuss terms and conditions of access.</conditions></useStmt></dataAccs><othrStdyMat><relMat>Ross S, Robert M, Ducey A.  The short life cycle of a surgical device - literature analysis using McKinlay's 7-stage model.  Health Policy Technol. 2015 Feb 23;4:168-188.</relMat><relPubl><citation><titlStmt><IDNo agency="doi">10.1186/1756-0500-7-941</IDNo></titlStmt><biblCit>Ross S, Tang S, Schulz J, et al. Single incision device (TVT Secur) versus retropubic tension-free vaginal tape device (TVT) for the management of stress urinary incontinence in women: a randomized clinical trial. BMC Research Notes. 2014;7:941.</biblCit></citation><ExtLink URI="https://www.ncbi.nlm.nih.gov/pubmed/25532604"/></relPubl></othrStdyMat></stdyDscr><otherMat ID="f6879" URI="https://dataverse.library.ualberta.ca/api/access/datafile/6879" level="datafile"><labl>Ross_research_manual_front_page_050509.doc</labl><txt>Front page of site research manual for  TVT Secur Versus TVT Randomised Controlled Trial.</txt><notes level="file" type="DATAVERSE:CONTENTTYPE" subject="Content/MIME Type">application/msword</notes></otherMat><otherMat ID="f6873" URI="https://dataverse.library.ualberta.ca/api/access/datafile/6873" level="datafile"><labl>Ross_TVT_Secur_12month_data_collection_050509.doc</labl><txt>12 Month Data Collection Form for TVT Secur Versus TVT Randomised Controlled Trial.</txt><notes level="file" type="DATAVERSE:CONTENTTYPE" subject="Content/MIME Type">application/msword</notes></otherMat><otherMat ID="f6872" URI="https://dataverse.library.ualberta.ca/api/access/datafile/6872" level="datafile"><labl>Ross_TVT_Secur_12month_questionnaire_Ed_050509.doc</labl><txt>12 Month Questionnaire for TVT Secur Versus TVT Randomised Controlled Trial.</txt><notes level="file" type="DATAVERSE:CONTENTTYPE" subject="Content/MIME Type">application/msword</notes></otherMat><otherMat ID="f6871" URI="https://dataverse.library.ualberta.ca/api/access/datafile/6871" level="datafile"><labl>Ross_TVT_Secur_6weeks_questionnaire_050509.doc</labl><txt>6 Week Data Collection Form for TVT Secur Versus TVT Randomised Controlled Trial.</txt><notes level="file" type="DATAVERSE:CONTENTTYPE" subject="Content/MIME Type">application/msword</notes></otherMat><otherMat ID="f6874" URI="https://dataverse.library.ualberta.ca/api/access/datafile/6874" level="datafile"><labl>Ross_TVT_Secur_adverse_event_form 2010-09-01.doc</labl><txt>Non-serious Adverse Event Form for TVT Secur Versus TVT Randomised Controlled Trial.</txt><notes level="file" type="DATAVERSE:CONTENTTYPE" subject="Content/MIME Type">application/msword</notes></otherMat><otherMat ID="f6868" URI="https://dataverse.library.ualberta.ca/api/access/datafile/6868" level="datafile"><labl>Ross_TVT_Secur_baseline_data_collection_r050509.doc</labl><txt>Baseline Data Collection Form for TVT Secur Versus TVT Randomised Controlled Trial.</txt><notes level="file" type="DATAVERSE:CONTENTTYPE" subject="Content/MIME Type">application/msword</notes></otherMat><otherMat ID="f6867" URI="https://dataverse.library.ualberta.ca/api/access/datafile/6867" level="datafile"><labl>Ross_TVT_Secur_baseline_questionnair- Ed 050509.doc</labl><txt>Baseline Questionnaire for TVT Secur Versus TVT Randomised Controlled Trial.</txt><notes level="file" type="DATAVERSE:CONTENTTYPE" subject="Content/MIME Type">application/msword</notes></otherMat><otherMat ID="f6878" URI="https://dataverse.library.ualberta.ca/api/access/datafile/6878" level="datafile"><labl>Ross_TVT_Secur_DSMC.doc</labl><txt>Charter for Data and Safety Monitoring Committee.</txt><notes level="file" type="DATAVERSE:CONTENTTYPE" subject="Content/MIME Type">application/msword</notes></otherMat><otherMat ID="f6876" URI="https://dataverse.library.ualberta.ca/api/access/datafile/6876" level="datafile"><labl>Ross_TVT_Secur_form_completion 250509.doc</labl><txt>Instructions for completing and submitting Forms to TVT Secur Study Office.</txt><notes level="file" type="DATAVERSE:CONTENTTYPE" subject="Content/MIME Type">application/msword</notes></otherMat><otherMat ID="f6870" URI="https://dataverse.library.ualberta.ca/api/access/datafile/6870" level="datafile"><labl>Ross_TVT_Secur_OR_data_collection_050509.doc</labl><txt>Operating Room (OR) Data Collection Form for TVT Secur Versus TVT Randomised Controlled Trial.</txt><notes level="file" type="DATAVERSE:CONTENTTYPE" subject="Content/MIME Type">application/msword</notes></otherMat><otherMat ID="f6877" URI="https://dataverse.library.ualberta.ca/api/access/datafile/6877" level="datafile"><labl>Ross_TVT_Secur_patient_forms_for_centre_use_only_190509.doc</labl><txt>Patient forms for office use only, including  case report form checklist, patient contact form, patient eligibility checklist, etc.</txt><notes level="file" type="DATAVERSE:CONTENTTYPE" subject="Content/MIME Type">application/msword</notes></otherMat><otherMat ID="f6875" URI="https://dataverse.library.ualberta.ca/api/access/datafile/6875" level="datafile"><labl>Ross_TVT_Secur_serious_adverse_event form_190509.doc</labl><txt>Serious Adverse Event Form for TVT Secur Versus TVT Randomised Controlled Trial.</txt><notes level="file" type="DATAVERSE:CONTENTTYPE" subject="Content/MIME Type">application/msword</notes></otherMat><otherMat ID="f6869" URI="https://dataverse.library.ualberta.ca/api/access/datafile/6869" level="datafile"><labl>Ross_TVT_Secur_study_protocol_280708.doc</labl><txt>Study Protocol for TVT Secur Versus TVT Randomised Controlled Trial. The scientific protocol for the study, including scientific rationale and references.</txt><notes level="file" type="DATAVERSE:CONTENTTYPE" subject="Content/MIME Type">application/msword</notes></otherMat><otherMat ID="f6866" URI="https://dataverse.library.ualberta.ca/api/access/datafile/6866" level="datafile"><labl>Ross_TVT Secur_working_protocol 120509.doc</labl><txt>Working protocol for TVT Secur Versus TVT Randomised Controlled Trial. It contains the practical details of doing the study (recruitment, randomization, patient follow-up, etc). It also contains a sample consent form.</txt><notes level="file" type="DATAVERSE:CONTENTTYPE" subject="Content/MIME Type">application/msword</notes></otherMat></codeBook>